CG Oncology (CGON) Receivables - Net (2023 - 2026)
CG Oncology's (CGON) quarterly Receivables - Net came in at $1.3 million in Q1 2026, up 269.57% YoY from $345000.0 in Q1 2025, and up 85.32% on a QoQ basis from $688000.0 in Q4 2025.
CG Oncology (CGON) Receivables - Net (2023 - 2026) Analysis & Trends
CG Oncology (CGON) has 4 years of Receivables - Net data on file, last reported at $1.3 million in Q1 2026.
- Quarterly Receivables - Net rose 269.57% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 269.57% YoY) and the FY2025 annual result came in at $688000.0, changed N/A from the prior year.
- Receivables - Net rose to $1.3 million in Q1 2026, from $688000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $1.3 million in Q1 2026 to a low of $92000.0 in Q4 2023.
- A 4-year average of $438777.8 and a median of $345000.0 in 2025 frame the typical range for Receivables - Net.
- The widest YoY moves for Receivables - Net: up 275.91% in 2025, down 125.49% in 2025.
- Tracing CGON's Receivables - Net over 4 years: stood at $92000.0 in 2023, then jumped by 48.91% to $137000.0 in 2024, then surged by 402.19% to $688000.0 in 2025, then jumped by 85.32% to $1.3 million in 2026.
- The last three Receivables - Net figures came in at $1.3 million (Q1 2026), $688000.0 (Q4 2025), and $515000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 417,000.00 |
| Jun 30, 2026 | 417,000.00 |
| Mar 31, 2026 | 1.28 Mn |
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 688,000.00 |
| Dec 31, 2025 | 688,000.00 |
| Sep 30, 2025 | 515,000.00 |
| Sep 30, 2025 | 515,000.00 |
| Jun 30, 2025 | 562,000.00 |
| Jun 30, 2025 | 562,000.00 |
| Mar 31, 2025 | 345,000.00 |
| Mar 31, 2025 | 345,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Dec 31, 2023 | 92,000.00 |